Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Percutaneous Mechanical Circulatory Support Devices Market From 2025 To 2034?
The market encompassing percutaneous mechanical circulatory support devices has experienced robust expansion lately, projected to ascend from a value of $2.26 billion in the year 2024 to $2.46 billion by 2025, reflecting a compound annual growth rate (CAGR) of 8.9%. This historical upward trajectory is primarily a consequence of the rising frequency of cardiovascular ailments, an expanding elderly demographic, a greater number of heart attack occurrences, heightened public consciousness alongside proactive screening initiatives, and a surging requirement for cardiac assist pumping apparatuses.
Forecasting robust expansion, the market encompassing percutaneous mechanical circulatory support devices is projected to attain a valuation of $3.55 billion by 2029, reflecting a consistent compound annual growth rate of 9.5% throughout the projection timeframe. This upward trajectory is fueled by several factors, notably the increasing need for sustained mechanical cardiac assistance, escalating global healthcare spending, a growing prevalence of both diabetes and obesity, the greater necessity for cardiac transplant options, and the wider adoption of catheter-based medical interventions. Key developments shaping this market segment going forward involve progress in pump innovation, ongoing improvements in medical device technology, advancements in cardiac assistance methodologies, the evolution of less invasive medical techniques, and the ongoing creation of materials that are better tolerated by biological systems.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp
What Are The Key Drivers Of Growth In The Percutaneous Mechanical Circulatory Support Devices Market?
Anticipated expansion in the market for percutaneous mechanical circulatory support devices is directly linked to the rising prevalence of affections of the heart and blood vessels, commonly known as cardiovascular diseases (CVDs), a category encompassing ailments like stroke, elevated blood pressure, heart failure, myocardial infarctions, and coronary artery disease. A confluence of elements contributes to this surge in CVD cases, notably demographic shifts toward an older population, suboptimal lifestyle habits, elevated rates of obesity and hypertension, alongside underlying genetic vulnerabilities. These percutaneous mechanical assist devices play a crucial role in managing CVD, serving to bolster heart performance, alleviate stress on the cardiac muscle, and foster recuperation during severe cardiac events; for example, data from the Australian Institute of Health and Welfare indicated that physician-confirmed fatalities attributed to coronary heart disease (CHD) climbed from 14,100 in 2021 to 14,900 across Australia in 2022, thereby underscoring how the growing burden of cardiovascular illness fuels the trajectory of the percutaneous MCS device sector.
What Are The Leading Segments Analyzed In The Percutaneous Mechanical Circulatory Support Devices Market?
The percutaneous mechanical circulatory support devicesmarket covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
What Long-Term Trends Will Shape The Future Growth Of The Percutaneous Mechanical Circulatory Support Devices Industry?
Leading firms within the arena of percutaneous mechanical circulatory support devices are channeling efforts toward innovating highly sophisticated apparatuses, notably intra-aortic axial-flow systems, with the dual aims of improving clinical results for patients and mitigating the perils associated with surgical interventions. This specific category of percutaneous mechanical circulatory support (MCS) equipment, known as an intra-aortic axial-flow device, functions by bolstering cardiac performance through the augmentation of blood movement directly from the left ventricle into the aorta. As an illustration, in the month of February in 2023, Procyrion, Inc., a medical technology corporation headquartered in the United States, shared news of the inaugural successful application in a human subject involving their Aortix pump. This novel mechanism has been engineered specifically to forestall acute kidney injury (AKI) in individuals undergoing heart operations. Through catheter delivery into the descending thoracic aorta, the Aortix pump serves to boost blood supply to the kidneys and lessen the effort expended by the heart throughout the surgical process. By simultaneously elevating perfusion to both the renal system and the broader circulatory network while concurrently lightening the cardiac burden, this technology presents significant benefits, particularly for those whose left ventricular function is already compromised or who suffer from kidney problems. The Aortix pump, which holds the capacity to move as much as 5.0 liters of fluid every minute, is slated for short-term application during various procedures, including percutaneous coronary interventions (PCI).
Who Are The Key Multinational Companies Dominating The Percutaneous Mechanical Circulatory Support Devices Market?
Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Percutaneous Mechanical Circulatory Support Devices Industry?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Percutaneous Mechanical Circulatory Support Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp
Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2025, By The Business Research Company
Mechanical Power Transmission Equipment Global Market Report 2025
Mechanical Ventilator Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/mechanical-ventilator-global-market-report
Microelectromechanical Systems Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model